Innovative heart rhythm technologies that do away with the leads that "tether" the device to the heart may be the next big thing for heart failure patients, but the technology has a way to go before disrupting the market, according to panelists at the Cardiostim 2012 conference in France this week.
Getting rid of the leads that weave through the body to deliver shocks to the heart would mean doing away with risks including lead fractures, erosion and infections, Cleveland Clinic’s Dr. Bruce Wilkoff told an audience at a popular presentation.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Cameron Health’s under-the-skin defibrillator may take longer to respond to cardiac events than standard implantable cardiac defibrillators, but speed isn’t always the most important factor in saving a life.
Although Cameron’s S-ICD took longer than 18 seconds to respond in 12% of patients in the ongoing Effortless study, it always responded in time with life-saving therapy and did so while delivering fewer inappropriate shocks to the heart.